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Sir,
Thank you for giving us the opportunity to respond to the
commentary letter by Dr Kovacs.
In the third paragraph, Dr Kovacs is referring to staging
methods. He compares four publications (Kovacs et al, 2001,
2004a,c; Ross et al, 2004) to our present publication in the British
Journal of Cancer (Ho ¨ft et al, 2004). One of the four studies was
published after ours (Ross et al, 2004). Two are not published yet,
but are in press (Kovacs et al, 2004a,c). Dr Kovacs’ conclusion that
‘sentinel lymph node biopsy reflected the accuracy of the clinical
and radiological staging methods, and the ideal diagnostic
prerequisite for SNB is not yet found’ is quite similar to ours,
namely the ‘better the staging methods are in detecting small
metastases the less occult metastases will be overlooked and the
more valuable will be the impact of an additional sentinel lymph
node procedure’. However, the rate of positive sentinel lymph
nodes is not only influenced by the staging procedure but also by
the pathohistologic work-up. The more the intensive sentinel
lymph nodes are examined, the more the occult metastases will be
detected, raising the percentage of patients with occult disease
(Ho ¨ft et al, 2002; Ho ¨ft et al, 2004). In our study, we applied
ultrasound examinations for staging of the neck as a radiological
method and also performed fine-needle aspiration cytologies. The
accuracy of US-guided aspiration cytology has been shown to be
significantly better than that of CT or MRI (van den Brekel et al,
1991).
The fourth paragraph concerns the obstacle of performing a
sentinel node biopsy on large tumours. In our group of patients,
this is due to the fact that it was difficult to perform an endoscopic
peritumoral injection on large tumours located in the pharynx and
the larynx (Ho ¨ft et al, 2004). Dr Kovacs adds that large tumours
pose problems due to destruction of the lymphatic drainage, but he
fails to provide data or literature on which his opinion is based. As
we did not perform histologic studies of the lymphatics, we cannot
add new information whether large tumours are more aggressive
in destroying lymphatic vessels on their rim than are small
tumours. However, the technique of the peritumoral injection is to
inject the tracer adjacent to, and not into, the tumour. Thus, it does
not really matter if a tumour destroys lymphatic vessels within its
borders, as there will be intact lymphatics surrounding the tumour
to take up the tracer even in large carcinomas.
In his last sentence of the fourth paragraph, Dr Kovacs suggests
that an intra-arterial induction chemotherapy might be a modality
in reducing tumour size prior to sentinel node biopsy. It is an
interesting suggestion we would have liked to discuss in our
article. However, Dr Kovacs’ results were still in press when his
letter of comment was written. Thus, the information he refers to
was not accessible to us. Yet, although Dr Kovacs states that intra-
arterial chemotherapy did not seem to alter lymphatic drainage
(Kovacs et al, 2004b), there is ample evidence that preoperative
chemotherapy affects lymph nodes. Cohen et al (2000) describe
lymph nodes showing areas of fibrosis, fat necrosis, histiocytic
accumulation and granulation formation after neoadjuvant che-
motherapy. Furthermore, metastatic foci can be completely
obliterated by chemotherapy. Accordingly, Nason et al (2000)
concluded in their study that preoperative chemotherapy is
associated with an unacceptable high false negative rate for
sentinel lymph node detection. If these changes are evident in
chemotherapy, we would expect to find them in patients with
intra-arterial chemotherapy, too. We are looking forward to the
publication of Dr Kovacs’ results and histologic findings of the
lymphatics.
In the fifth paragraph, Dr Kovacs refers to the omission of an
elective neck dissection potentially achieving a benefit for the *Correspondence: Dr S Hoft, E-mail: hoft@hno.uni-kiel.de
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complains that Ross et al (2002) were not the first to publish a true
sentinel node biopsy, but Dr Kovacc himself (Kovacs et al, 2001).
Furthermore, he is citing three articles by himself that have not
been published yet (Kovacs et al, 2004a,b,c), mentioning 80
patients who underwent a sentinel node biopsy. At the point of
time we wrote and published our article, only the first publication
was available in the German literature (Kovacs et al, 2001). Dr
Kovacs’ method included a therapy of the primary tumour prior to
sentinel node biopsy by performing an intra-arterial chemotherapy
in 12 of 15 patients. In his article, the author did not discuss the
problem of chemotherapy causing changes in the lymphatic
drainage of the tumour. Yet, as discussed above, there was
literature pointing out the disadvantages of prior chemotherapy.
Therefore, we are of the opinion that unless proven otherwise, the
methodical approach of treating the primary tumour prior to
sentinel node biopsy bears the risk of false negative results.
If an elective therapy of the neck such as neck dissection or
radiotherapy is omitted in favour of a true sentinel node biopsy, it
is with the intent of causing less morbidity and achieving more
quality of life for the patient. However, since a true biopsy of the
sentinel node is not yet established for head and neck cancer, we
formulated as a prerequisite that patients with a mere biopsy of the
sentinel nodes should have equal regional control rates as patients
after elective therapy of the neck. This mandates that no additional
elective therapy is performed before or after sentinel node biopsy.
Otherwise the rate of recurrences after mere sentinel node biopsy
does not only present the quality of staging by sentinel node biopsy
but also the quality of elective therapy of the neck. In his group of
patients, Dr Kovacs performed an elective radiochemotherapy of
the neck after sentinel node biopsy applying 51.3Gy and docetaxel
(25mgm
2 once a week) over a period of 5 weeks (Kovacs et al,
2001). It is our opinion that the method designed by Dr Kovacs will
result in biased data. His method does not represent a true sentinel
node biopsy and is likely to discredit the sentinel node concept.
Therefore, we cited Ross et al (2002) as they indeed were the first to
publish a study on a true sentinel node biopsy without prior
therapy of the primary tumour and postoperative radiotherapy of
the lymphatics in the international literature.
We are still cautious about a true sentinel node biopsy in head
and neck cancer and are looking forward to long-term results in
comparison to elective selective neck dissection.
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